114 related articles for article (PubMed ID: 9660843)
1. Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women.
Allard S; Sainati S; Roth-Schechter B; MacIntyre J
Drug Metab Dispos; 1998 Jul; 26(7):617-22. PubMed ID: 9660843
[TBL] [Abstract][Full Text] [Related]
2. The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.
Piergies AA; Sweet J; Johnson M; Roth-Schechter BF; Allard S
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):178-83. PubMed ID: 8861737
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers.
Vlase L; Leucuta A; Farcau D; Nanulescu M
Biopharm Drug Dispos; 2006 Sep; 27(6):285-9. PubMed ID: 16770757
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers.
Breuel HP; Müller-Oerlinghausen B; Nickelsen T; Heine PR
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):415-9. PubMed ID: 7582400
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers.
Vlase L; Popa A; Neag M; Muntean D; Bâldea I; Leucuţa SE
J Clin Pharmacol; 2011 Aug; 51(8):1233-6. PubMed ID: 21098143
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Greenblatt DJ; von Moltke LL; Harmatz JS; Mertzanis P; Graf JA; Durol AL; Counihan M; Roth-Schechter B; Shader RI
Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
[TBL] [Abstract][Full Text] [Related]
8. Rifampin reduces plasma concentrations and effects of zolpidem.
Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
[TBL] [Abstract][Full Text] [Related]
9. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
11. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
Barkin RL
Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of fluoxetine in elderly men and women.
Ferguson JM; Hill H
Gerontology; 2006; 52(1):45-50. PubMed ID: 16439824
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of short-term zolpidem with sertraline in healthy women.
Allard S; Sainati SM; Roth-Schechter BF
J Clin Pharmacol; 1999 Feb; 39(2):184-91. PubMed ID: 11563412
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
17. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
18. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
Weerts EM; Ator NA; Grech DM; Griffiths RR
J Pharmacol Exp Ther; 1998 Apr; 285(1):41-53. PubMed ID: 9535993
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.
Greenblatt DJ; Legangneux E; Harmatz JS; Weinling E; Freeman J; Rice K; Zammit GK
J Clin Pharmacol; 2006 Dec; 46(12):1469-80. PubMed ID: 17101746
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
Martin DE; Galbraith H; Schettler J; Ellis C; Doto J
Clin Ther; 2008 Oct; 30(10):1794-805. PubMed ID: 19014835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
